242 related articles for article (PubMed ID: 31209986)
1. Fetal RHD detection from circulating cell-free fetal DNA in maternal plasma: validation of a diagnostic kit using automatic extraction and frozen DNA.
Londero D; Stampalija T; Bolzicco D; Castro Silva E; Candolini M; Cortivo C; Dreossi C; Fantasia I; Pecile V; De Angelis V
Transfus Med; 2019 Dec; 29(6):408-414. PubMed ID: 31209986
[TBL] [Abstract][Full Text] [Related]
2. Determination of fetal RHD type in plasma of RhD negative pregnant women.
Sørensen K; Kjeldsen-Kragh J; Husby H; Akkök ÇA
Scand J Clin Lab Invest; 2018 Sep; 78(5):411-416. PubMed ID: 29869532
[TBL] [Abstract][Full Text] [Related]
3. Prenatal non-invasive foetal RHD genotyping: diagnostic accuracy of a test as a guide for appropriate administration of antenatal anti-D immunoprophylaxis.
Manfroi S; Calisesi C; Fagiani P; Gabriele A; Lodi G; Nucci S; Pelliconi S; Righini L; Randi V
Blood Transfus; 2018 Nov; 16(6):514-524. PubMed ID: 29757138
[TBL] [Abstract][Full Text] [Related]
4. Non-invasive fetal RHD exon 7 and exon 10 genotyping using real-time PCR testing of fetal DNA in maternal plasma.
Hromadnikova I; Vechetova L; Vesela K; Benesova B; Doucha J; Kulovany E; Vlk R
Fetal Diagn Ther; 2005; 20(4):275-80. PubMed ID: 15980640
[TBL] [Abstract][Full Text] [Related]
5. Prenatal screening service for fetal RHD genotyping to guide prophylaxis: the two-year experience of the Friuli Venezia Giulia region in Italy.
Londero D; Merluzzi S; Dreossi C; Barillari G
Blood Transfus; 2023 Mar; 21(2):93-99. PubMed ID: 35848630
[TBL] [Abstract][Full Text] [Related]
6. Noninvasive fetal RHD genotyping from maternal plasma. Use of a new developed Free DNA Fetal Kit RhD.
Rouillac-Le Sciellour C; Sérazin V; Brossard Y; Oudin O; Le Van Kim C; Colin Y; Guidicelli Y; Menu M; Cartron JP
Transfus Clin Biol; 2007 Dec; 14(6):572-7. PubMed ID: 18375165
[TBL] [Abstract][Full Text] [Related]
7. Genotyping approach for non-invasive foetal RHD detection in an admixed population.
Boggione CT; Luján Brajovich ME; Mattaloni SM; Di Mónaco RA; García Borrás SE; Biondi CS; Cotorruelo CM
Blood Transfus; 2017 Jan; 15(1):66-73. PubMed ID: 27136427
[TBL] [Abstract][Full Text] [Related]
8. Assessment of Fetal Rhesus D and Gender with Cell-Free DNA and Exosomes from Maternal Blood.
Yaşa B; Şahin O; Öcüt E; Seven M; Sözer S
Reprod Sci; 2021 Feb; 28(2):562-569. PubMed ID: 32968935
[TBL] [Abstract][Full Text] [Related]
9. A new biosensor for noninvasive determination of fetal RHD status in maternal blood of RhD negative pregnant women.
Dündar Yenilmez E; Kökbaş U; Kartlaşmış K; Kayrın L; Tuli A
PLoS One; 2018; 13(6):e0197855. PubMed ID: 29874251
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of an automated platform for non-invasive single-exon fetal RHD genotyping early in pregnancy.
Isakson P; Pardi C
Blood Transfus; 2023 Nov; 21(6):472-478. PubMed ID: 36795345
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of RhD status and clinical application of non-invasive prenatal determination of fetal RHD in maternal plasma: a 5 year experience in Cyprus.
Papasavva T; Martin P; Legler TJ; Liasides M; Anastasiou G; Christofides A; Christodoulou T; Demetriou S; Kerimis P; Kontos C; Leontiades G; Papapetrou D; Patroclos T; Phylaktou M; Zottis N; Karitzie E; Pavlou E; Kountouris P; Veldhuisen B; van der Schoot E; Kleanthous M
BMC Res Notes; 2016 Apr; 9():198. PubMed ID: 27036548
[TBL] [Abstract][Full Text] [Related]
12. Non-invasive fetal RHD genotyping in the first trimester of pregnancy.
Cardo L; García BP; Alvarez FV
Clin Chem Lab Med; 2010 Aug; 48(8):1121-6. PubMed ID: 20482298
[TBL] [Abstract][Full Text] [Related]
13. RHD genotyping from maternal plasma: guidelines and technical challenges.
Avent ND
Methods Mol Biol; 2008; 444():185-201. PubMed ID: 18425481
[TBL] [Abstract][Full Text] [Related]
14. Standardization non-invasive fetal RHD and SRY determination into clinical routine using a new multiplex RT-PCR assay for fetal cell-free DNA in pregnant women plasma: results in clinical benefits and cost saving.
Macher HC; Noguerol P; Medrano-Campillo P; Garrido-Márquez MR; Rubio-Calvo A; Carmona-González M; Martin-Sánchez J; Pérez-Simón JA; Guerrero JM
Clin Chim Acta; 2012 Feb; 413(3-4):490-4. PubMed ID: 22133782
[TBL] [Abstract][Full Text] [Related]
15. External quality assessment of noninvasive fetal RHD genotyping.
Clausen FB; Hellberg Å
Vox Sang; 2020 Jul; 115(5):466-471. PubMed ID: 32166750
[TBL] [Abstract][Full Text] [Related]
16. Noninvasive fetal RHD genotyping from maternal plasma in an admixed Brazilian population.
Schmidt LC; Cabral AC; Faria MA; Monken F; Tarazona-Santos E; Martins ML
Genet Mol Res; 2014 Feb; 13(1):799-805. PubMed ID: 24615044
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic accuracy of fetal rhesus D genotyping using cell-free fetal DNA during the first trimester of pregnancy.
Vivanti A; Benachi A; Huchet FX; Ville Y; Cohen H; Costa JM
Am J Obstet Gynecol; 2016 Nov; 215(5):606.e1-606.e5. PubMed ID: 27393271
[TBL] [Abstract][Full Text] [Related]
18. Noninvasive fetal RHD genotyping to guide targeted anti-D prophylaxis-an external quality assessment workshop.
Clausen FB; Barrett AN;
Vox Sang; 2019 May; 114(4):386-393. PubMed ID: 30834546
[TBL] [Abstract][Full Text] [Related]
19. Determination of Rh type and gender using circulating cell-free fetal DNA in early pregnancy of Rh negative women in turkey.
Elgun T; Musteri Oltulu Y; Gok Yurttas A; Agyuz U; Ozkal Molla F; Kilic U
Transfus Clin Biol; 2023 Aug; 30(3):324-328. PubMed ID: 37116742
[TBL] [Abstract][Full Text] [Related]
20. Antenatal
Clausen FB
Immunohematology; 2024 Apr; 40(1):15-27. PubMed ID: 38739027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
